NeOnc Technologies Holdings, Inc. Common Stock

NASDAQ:NTHI USA Biotechnology
Market Cap
$154.31 Million
Market Cap Rank
#20037 Global
#7298 in USA
Share Price
$8.11
Change (1 day)
-8.47%
52-Week Range
$3.35 - $12.09
All Time High
$12.09
About

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical… Read more

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.492x

Based on the latest financial reports, NeOnc Technologies Holdings, Inc. Common Stock (NTHI) has a cash flow conversion efficiency ratio of 0.492x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.81 Million) by net assets ($-11.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NeOnc Technologies Holdings, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how NeOnc Technologies Holdings, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

NeOnc Technologies Holdings, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NeOnc Technologies Holdings, Inc. Common Stock ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for NeOnc Technologies Holdings, Inc. Common Stock (2021–2024)

The table below shows the annual cash flow conversion efficiency of NeOnc Technologies Holdings, Inc. Common Stock from 2021 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-5.50 Million $-4.21 Million 0.765x +469.55%
2023-12-31 $-13.99 Million $-1.88 Million 0.134x -75.99%
2022-12-31 $-1.58 Million $-881.74K 0.560x +269.14%
2021-12-31 $-2.62 Million $-396.69K 0.152x --